Analysts predict that Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) will announce $545.90 million in sales for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have issued estimates for Allscripts Healthcare Solutions’ earnings, with the lowest sales estimate coming in at $520.38 million and the highest estimate coming in at $552.90 million. Allscripts Healthcare Solutions reported sales of $451.20 million during the same quarter last year, which would suggest a positive year over year growth rate of 21%. The business is scheduled to report its next quarterly earnings report after the market closes on Thursday, November 1st.

According to Zacks, analysts expect that Allscripts Healthcare Solutions will report full year sales of $2.17 billion for the current financial year, with estimates ranging from $2.16 billion to $2.21 billion. For the next fiscal year, analysts expect that the firm will post sales of $2.26 billion, with estimates ranging from $2.17 billion to $2.29 billion. Zacks’ sales calculations are an average based on a survey of research firms that follow Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, August 2nd. The software maker reported $0.18 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.18. The business had revenue of $525.50 million during the quarter, compared to analysts’ expectations of $536.93 million. Allscripts Healthcare Solutions had a return on equity of 8.26% and a net margin of 0.10%. The business’s revenue was up 23.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.15 earnings per share.

A number of analysts have recently commented on MDRX shares. Cantor Fitzgerald restated a “buy” rating and issued a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Thursday, August 2nd. ValuEngine cut Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Friday, July 20th. TheStreet upgraded Allscripts Healthcare Solutions from a “c+” rating to a “b-” rating in a research report on Thursday, September 6th. Zacks Investment Research cut Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Thursday, October 4th. Finally, Canaccord Genuity dropped their price target on Allscripts Healthcare Solutions from $17.00 to $16.00 and set a “buy” rating for the company in a research report on Friday, August 3rd. One research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $16.38.

Shares of Allscripts Healthcare Solutions stock traded up $0.21 on Monday, reaching $13.38. The company’s stock had a trading volume of 4,106,720 shares, compared to its average volume of 1,810,688. The stock has a market capitalization of $2.49 billion, a PE ratio of 28.47, a price-to-earnings-growth ratio of 1.88 and a beta of 1.14. Allscripts Healthcare Solutions has a 52-week low of $10.78 and a 52-week high of $16.13. The company has a debt-to-equity ratio of 1.41, a current ratio of 0.94 and a quick ratio of 0.94.

Allscripts Healthcare Solutions announced that its Board of Directors has approved a stock buyback program on Thursday, August 2nd that permits the company to buyback $250.00 million in shares. This buyback authorization permits the software maker to purchase up to 11.3% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its shares are undervalued.

In other Allscripts Healthcare Solutions news, CFO Dennis Olis sold 25,000 shares of the business’s stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $14.50, for a total transaction of $362,500.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Brian Farley sold 6,000 shares of the business’s stock in a transaction on Friday, September 14th. The stock was sold at an average price of $14.67, for a total value of $88,020.00. Following the transaction, the executive vice president now directly owns 242,673 shares in the company, valued at approximately $3,560,012.91. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Summit Trail Advisors LLC acquired a new position in Allscripts Healthcare Solutions during the second quarter worth $105,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Allscripts Healthcare Solutions during the second quarter worth $160,000. Fox Run Management L.L.C. acquired a new position in Allscripts Healthcare Solutions during the second quarter worth $204,000. Whittier Trust Co. of Nevada Inc. acquired a new position in Allscripts Healthcare Solutions during the second quarter worth $229,000. Finally, Hancock Holding Co. acquired a new position in Allscripts Healthcare Solutions during the first quarter worth $333,000.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Recommended Story: How is a Moving Average Calculated?

Get a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.